22nd Century Group Inc (NYSEAMERICAN:XXII) Shares Sold by Advisory Services Network LLC

Advisory Services Network LLC decreased its position in shares of 22nd Century Group Inc (NYSEAMERICAN:XXII) by 12.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,979 shares of the biotechnology company’s stock after selling 7,054 shares during the period. Advisory Services Network LLC’s holdings in 22nd Century Group were worth $85,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of XXII. Mercer Global Advisors Inc. ADV bought a new position in shares of 22nd Century Group in the first quarter worth about $28,000. HRT Financial LLC purchased a new position in shares of 22nd Century Group in the 4th quarter valued at approximately $33,000. D. E. Shaw & Co. Inc. acquired a new position in 22nd Century Group in the 4th quarter worth approximately $33,000. GSA Capital Partners LLP acquired a new position in 22nd Century Group in the 4th quarter worth approximately $38,000. Finally, Principal Financial Group Inc. acquired a new position in 22nd Century Group in the 4th quarter worth approximately $40,000.

Shares of NYSEAMERICAN XXII traded down $0.02 during trading on Thursday, hitting $1.91. 858,743 shares of the company were exchanged, compared to its average volume of 1,528,352. 22nd Century Group Inc has a 12-month low of $1.58 and a 12-month high of $3.29.

22nd Century Group (NYSEAMERICAN:XXII) last posted its quarterly earnings results on Tuesday, May 7th. The biotechnology company reported ($0.02) EPS for the quarter. The firm had revenue of $6.29 million during the quarter.

In related news, VP Thomas L. James sold 48,000 shares of the firm’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $2.11, for a total transaction of $101,280.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

A number of equities research analysts have recently commented on XXII shares. Chardan Capital reaffirmed a “buy” rating and set a $11.50 price objective on shares of 22nd Century Group in a research note on Wednesday, May 8th. TheStreet cut shares of 22nd Century Group from a “c-” rating to a “d+” rating in a research note on Friday, March 29th.

22nd Century Group Company Profile

22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies.

Featured Article: Risk Tolerance and Your Investment Decisions

Institutional Ownership by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.